Currently, we showed that pre- and post-treatments significantly reduced tumor growth, downregulated ROS levels, enhanced antioxidant defense mechanisms, and suppressed survivin and elevated Casp3 expressions. The gene discussed is BIRC5; the disease is neoplasm.